Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial.

Utako Okata-KariganePirunthan PathmarajahEmily S GorellKatie SumKiana YekrangMichelle PhungMelissa BarrigaPatricia UdrizarIrene BaileyShufeng LiYing LuJean Y TangAlbert S Chiou

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)

Keyphrases

randomized controlled trial
study protocol
meta analyses